Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950142-21-001061
Filing Date
2021-03-25
Accepted
2021-03-25 18:01:13
Documents
1
Period of Report
2021-03-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT es210138417_4-finch.html 4  
1 OWNERSHIP DOCUMENT es210138417_4-finch.xml 4 15242
  Complete submission text file 0000950142-21-001061.txt   17194
Mailing Address 28 HAVEMEYER PLACE GREENWICH CT 06830
Business Address
Shumway Chris (Reporting) CIK: 0001222119 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40227 | Film No.: 21773775

Mailing Address 200 INNER BELT ROAD SOMERVILLE MA 02143
Business Address 200 INNER BELT ROAD SOMERVILLE MA 02143 617-229-6499
Finch Therapeutics Group, Inc. (Issuer) CIK: 0001733257 (see all company filings)

EIN.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 28 HAVEMEYER PLACE GREENWICH CT 06830
Business Address 28 HAVEMEYER PLACE GREENWICH CT 06830 203-485-8550
Crestovo Investor LLC (Reporting) CIK: 0001849829 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40227 | Film No.: 21773776